FMR1 and fragile X-associated tremor/ataxia syndrome: Second, it is possible that clinical rating scales are less sensitive than our quantitative approaches for identifying subtle or early indicators of FXTAS, particularly from a subclinical sample of FMR1 premutation carriers.